Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 2788  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Detection rate of prostate cancer using prostate specific antigen in patients presenting with lower urinary tract symptoms: A retrospective study

Chavan P R, Chavan S V, Chavan N R, Trivedi V D

Year : 2009| Volume: 55| Issue : 1 | Page no: 17-21

   This article has been cited by
 
1 Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients
Samuel W. D. Merriel, Lucy Pocock, Emma Gilbert, Sam Creavin, Fiona M. Walter, Anne Spencer, Willie Hamilton
BMC Medicine. 2022; 20(1)
[Pubmed]  [Google Scholar] [DOI]
2 The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20?ng/mL
Zhi-bing Wang, Chao-gang Wei, Yue-yue Zhang, Peng Pan, Guang-cheng Dai, Jian Tu, Jun-kang Shen, Tobias De Zordo
BioMed Research International. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
3 Effects of Age and PSA on the Positive Rate of Prostate Cancer Biopsy
?? ?
Advances in Clinical Medicine. 2020; 10(12): 3151
[Pubmed]  [Google Scholar] [DOI]
4 Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 1 of 2
Amit Ghose, Makarand Khochikar, Ravindra Sabnis, Naveen Magendra Parmar, Indranil Purkait
The Korean Journal of Urological Oncology. 2020; 18(3): 170
[Pubmed]  [Google Scholar] [DOI]
5 Outcomes of standard 12-core transrectal ultrasound-guided prostate biopsy in biopsy naive Indian men -single center experience
Abhishek Laddha, Appu Thomas, DeepakChandran Nair, GreeshmaC Ravindran, GinilKumar Pooleri
Indian Journal of Urology. 2020; 36(3): 179
[Pubmed]  [Google Scholar] [DOI]
6 Outcome of TRUS Biopsy with Limited Cores in Patients with PSA More Than 50ng/dL: Can We Reduce the Number of Cores Without Affecting Outcomes?
Abhishek Laddha, Appu Thomas, Deepak Chandran Nair, Greeshma C. Ravindran, Ginil Kumar Pooleri
Indian Journal of Surgical Oncology. 2020; 11(3): 509
[Pubmed]  [Google Scholar] [DOI]
7 A STUDY ON DIFFERENT TYPES OF THE PROSTATE CARCINOMAS
Sridhar Reddy K., Venkata Ramana P. , Vineetha N. , Harshitha C. , Sumalatha A. , Vinitha Sasi D.
Journal of Evidence Based Medicine and Healthcare. 2019; 6(27): 1863
[Pubmed]  [Google Scholar] [DOI]
8 Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study
Alexandre Peltier,Fouad Aoun,Vincent De Ruyter,Patrick Cabri,Roland Van Velthoven
Prostate Cancer. 2015; 2015: 1
[Pubmed]  [Google Scholar] [DOI]
9 Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10?ng/mL and non-suspicious digital rectal examination
Masaya Ito,Hitoshi Masuda,Satoru Kawakami,Yasuhisa Fujii,Fumitaka Koga,Kazutaka Saito,Shinya Yamamoto,Junji Yonese,Iwao Fukui,Kazunori Kihara
International Journal of Urology. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
10 Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?
Oh, J.J. and Jeong, S.J. and Jeong, C.W. and Byun, S.-S. and Hong, S.K. and Choe, G. and Lee, S.E.
Prostate. 2013; 73(1): 42-47
[Pubmed]  [Google Scholar]
11 Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?
Jong Jin Oh, Seong Jin Jeong, Chang Wook Jeong, Seok-Soo Byun, Sung Kyu Hong, Gheeyoung Choe, Sang Eun Lee
The Prostate. 2012; : n/a
[HTML Full text]  [Google Scholar] [DOI]
12 A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml
Chavan, S.V. and Chavan, N.R. and Balaji, A. and Trivedi, V.D. and Chavan, P.R.
Indian Journal of Medical Research. 2011; 134(10): 458-462
[Pubmed]  [Google Scholar]
13 Prostate biopsy findings in Indian men: A hospital-based study
Sinha, S. and Siriguri, S.R. and Kanakmedala, S.K. and Bikkasani, K.
Indian Journal of Cancer. 2011; 48(2): 175-180
[Pubmed]  [Google Scholar]
14 Is there an optimal prostate-specific antigen threshold for prostate biopsy?
Carsten Stephan, Kurt Miller, Klaus Jung
Expert Review of Anticancer Therapy. 2011; 11(8): 1215
[HTML Full text]  [Google Scholar] [DOI]
15 Genetic variants in the distal enhancer region of the PSA gene and their implication in the occurrence of advanced prostate cancer
Chavan, S.V. and Maitra, A. and Roy, N. and Patwardhan, S. and Chavan, P.R.
Molecular Medicine Reports. 2010; 3(5): 837-843
[Pubmed]  [Google Scholar]
16 Cut-off value for PSA: Do we need a change
Singh, J.C.
Journal of Postgraduate Medicine. 2009; 55(2): 150-151
[Pubmed]  [Google Scholar]

 

Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow